Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Turkey Aims To Bargain With Drug Firms To Ease Costs And Shortages

This article was originally published in PharmAsia News

Executive Summary

Turkey’s latest plan to ease shortages of mainly imported drugs for oncology and other chronic diseases while keeping a lid on reimbursement costs is to strike bargains with individual firms. But industry analysts are skeptical that systemic problems linked to exchange rate terms and growing demand will be solved by a new draft regulation allowing the Social Security Institution of Turkey, or SGK, to reach such deals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC087818

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel